The isoenzyme pattern of enolase was examined in the aqueous humour and serum of patients with retinoblastoma (10 aqueous, 8 sera), malignant melanoma (4 aqueous, 25 sera), and normal subjects undergoing cataract surgery (25 aqueous, 30 sera). The assay we used allowed assessment of all three major isoenzymes, including the yy isoenzyme (neurone-specific enolase). No enolase was detectable in normal aqueous; aa isoenzyme was present in the aqueous of one patient with malignant melanoma, while aqueous from all patients with retinoblastoma contained both aa and yy. Normal serum contained only an aa band, while serum from patients with retinoblastoma contained aa, ay, and yy bands (7 sera, 87-5%), or aa only (1 patient, 12-5%). All sera from patients with malignant melanoma contained the aa band, with low levels of yy in 16 (60%). In a single patient with Coats's disease aa was present in the serum, but no enolase was detected in aqueous. Increased amounts of y-containing isoenzymes of enolase are found in both serum and aqueous from patients with retinoblastoma. In malignant melanoma there is often an increase in serum yy enolase. The assessment of aqueous and serum enolase patterns may be of value in the diagnosis of retinoblastoma and malignant melanoma. The neurone-specific isoenzyme (yy) of enolase is demonstrable in tumours of neuroectodermal origin, such as retinoblastoma and neuroblastoma, 2 in aqueous humour from patients with retinoblastoma,3 and in serum4 and urine' from patients with neuroblastoma. Specific information about isoenzymes is yielded by measurement by radioimmunoassay,67 enzyme immunoassay,89 and electrophoretic separation,'0 but not by assays based on spectrophotometry'' II or luminescence.'2 13 Modification'4 of the electrophoretic assay, with a fluorescent endpoint, makes it more sensitive and rapid, allowing its application to small samples.
The neurone-specific isoenzyme (yy) of enolase is demonstrable in tumours of neuroectodermal origin, such as retinoblastoma and neuroblastoma, 2 in aqueous humour from patients with retinoblastoma,3 and in serum4 and urine' from patients with neuroblastoma. Specific information about isoenzymes is yielded by measurement by radioimmunoassay,67 enzyme immunoassay,89 and electrophoretic separation,'0 but not by assays based on spectrophotometry'' II or luminescence.'2 13 Modification'4 of the electrophoretic assay, with a fluorescent endpoint, makes it more sensitive and rapid, allowing its application to small samples.
We wished to investigate the patterns of enolase isoenzymes in aqueous and serum from patients with malignant ocular tumours, and we describe here our of the plate, and electrophoresis was carried out in tris barbital sodium buffer at 300 V for 7 minutes at room temperature. At the same time, the other (substrate) plate was placed membrane side up on a clean glass slide and 1 ml of isoenzyme reagent was poured on to the surface and allowed to soak for the period of electrophoresis. Following electrophoresis the sample plate was carefully placed on the substrate plate with the two wet surfaces apposed. The plates were -compressed between prewarmed (37°C) glass plates and incubated at 37°C for 25 minutes. The plates were separated and dried at approxi- (Table I) . No enolase was detected in normal aqueous humour, and normal serum contained only the aa band with relative intensity ranging from 1+ to 2+. Aqueous humour from all eyes with retinoblastoma contained aa and yy bands, with one sample also containing an intermediate (ay) band (Fig 1) . There was considerable variation in the relative intensities of the individual bands. Serum from all retinoblastoma patients contained an aa band, 7/8 (87 5%) also containing ay and yy bands (Fig   2) .
An aa band was visible in aqueous humour from one patient of the four with malignant melanoma, but in none could ay or yy be demonstrated. The aa band was present in the serum of all 25 malignant melanoma patients, with relative intensities ranging from 1 + to 2+, and in 16 yy (1+) was also present (Fig 3) . In a single case of Coats's disease, an aa band was present in the serum with no enzyme visible in the aqueous.
Discusssion
Enolase (2-phospho-D-glycerate hydrolase, EC 4.2.1.11) is widely distributed in tissues, and reversibly catalyses the conversion of 2-phosphoglycerate to phosphoenol pyruvate. Its isoenzymes are dimers consisting of two subunits coded for by three gene loci (a, 13, and y"). In most adult tissues only the aa dimer is present, while in adult muscle and heart the 13 dimer predominates though a13 hybrids are demonstrable in the heart.'0 Since the y subunit was previously believed to be expressed exclusively in mature neurones, yy isoenzyme was designated neurone-specific enolase (NSE). However, low levels of NSE are present in some non-neuronal tissues.'5 16 The enzyme is not bound to cellular membranes and probably escapes freely following cell injury. y-Subunits (that is, ay and yy'7) containing enolase isoenzymes have been Using an electrophoretic assay'4 we have demonstrated different enolase isoenzyme patterns in aqueous humour and serum. Three bands were identified, corresponding to those previously reported to be aa, ay and yy isoenzymes. Aqueous from patients with retinoblastoma contains aa and yy bands, while their serum often contains all three bands. The y bands were absent from normal sera and normal aqueous but were faintly present as the yy band in serum from two-thirds of patients with malignant melanoma. There were no differences between the sexes.
The presence of raised levels of NSE in serum and aqueous from patients with retinoblastoma is expected because of the presumed neuroectodermal origin of this tumour and its previous demonstration in tumour tissue. ' 
